Z-1189-2008
Bio-Rad MONOLISA Anti-HBc EIA, Catalog Number 26186. In vitro diagnostic
Bio-Rad Laboratories Inc. / initiated 2008-01-07 / Terminated / root cause: manufacturing process
Bio-Rad Laboratories began a recall of Bio-Rad MONOLISA Anti-HBc EIA, Catalog Number 26186. In vitro diagnostic on . The reason FDA records is "Incorrect result: Elevated reactivity with a kit lot 232BGG. Patient samples that are negative for antibodies to anti-HBc could be assigned a positive result". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.
Recall record
- Recall number
- Z-1189-2008
- Status
- Terminated
- Initiated
- Posted
- Terminated
- Recalling firm
- Bio-Rad Laboratories Inc.
- Product
- Bio-Rad MONOLISA Anti-HBc EIA, Catalog Number 26186. In vitro diagnostic.
- Reason for recall
- Incorrect result: Elevated reactivity with a kit lot 232BGG. Patient samples that are negative for antibodies to anti-HBc could be assigned a positive result.
- Root cause tag
- manufacturing process
- FDA root cause
- Process control
- Action
- Bio-Rad called each customer and alerted them to the issue on 1/7-8/2008. A letter was faxed and sent via overnight carrier (DHL) to each customer site on 1/8/2008. Customers were told not to use the affected lot of the product and to discard it. The firm will provide another lot of the product to customers.
- Quantity in commerce
- 31 distributed
- Distribution
- Nationwide Distribution.
- Product codes and lots
- Lot Number 232BGG
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
